Rachel Wattier, MD, MHS

TitleAssistant Professor
InstitutionUniversity of California San Francisco
Address550 16th. Street
San Francisco CA 94158
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, San Francisco, CAFellowship06/2015Pediatric Infectious Diseases
    University of California, San Francisco, San Francisco, CAFellowship06/2015Clinical Pharmacology
    University of California, San Francisco, San Francisco, CACertificate Program05/2015Advanced Training in Clinical Research
    University of California, San Francisco, San Francisco, CAResidency 06/2012Pediatrics
    Yale University, New Haven, CTM.D., M.H.S.05/2009School of Medicine
    University of Kentucky, Lexington, KYB.S.05/2004Biology, Agricultural Biotechnology

    Collapse Overview 
    Collapse Overview
    Rachel Wattier, M.D., M.H.S., who joined the Department of Pediatrics, Division of Infectious Diseases and Global Health in July 2015, serves as Medical Director of the Pediatric Antimicrobial Stewardship Program at UCSF Benioff Children’s Hospital San Francisco. In this role, she collaborates with pharmacists, nurses and physicians to ensure that patients receive timely therapy with the right antibiotic, at the right dose, for the right duration, with appropriate de-escalation when antibiotics are no longer needed.

    Dr. Wattier provides care to patients on the inpatient Pediatric Infectious Diseases Consultation Service and outpatient Pediatric Infectious Diseases Clinic. She is a member of the UCSF Immunocompromised Host Infectious Diseases Program and is involved in clinical research and care for children immunocompromised due to transplantation, chemotherapy, or primary immunodeficiencies. She is involved in multicenter research protocols through the International Pediatric Fungal Network and other pediatric research collaborations.

    Collapse ORNG Applications 
    Collapse Student Projects

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wattier RL, Levy ER, Sabnis AJ, Dvorak CC, Auerbach AD. Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infect Control Hosp Epidemiol. 2017 Sep; 38(9):1039-1047. PMID: 28758610.
      View in: PubMed
    2. Esbenshade AJ, Zhao Z, Aftandilian C, Saab R, Wattier RL, Beauchemin M, Miller TP, Wilkes JJ, Kelly MJ, Fernbach A, Jeng M, Schwartz CL, Dvorak CC, Shyr Y, Moons KGM, Sulis ML, Friedman DL. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia. Cancer. 2017 Oct 01; 123(19):3781-3790. PMID: 28542918.
      View in: PubMed
    3. Wattier RL, Ramirez-Avila L. Pediatric Invasive Aspergillosis. J Fungi (Basel). 2016 Jun 13; 2(2). PMID: 29376936.
      View in: PubMed
    4. Wattier RL, Ramirez-Avila L.Pediatric invasive aspergillosis. Journal of Fungi. 2016; 19(2).
    5. Horn B, O'Kane S, Wattier RL, Wahlstrom JT, Melton A, Cowan MJ, Dvorak CC. Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab. Bone Marrow Transplant. 2016 11; 51(11):1510-1512. PMID: 27272452.
      View in: PubMed
    6. Wattier RL, Dvorak CC, Auerbach AD, Weintrub PS. Repeat blood cultures in children with persistent fever and neutropenia: Diagnostic and clinical implications. Pediatr Blood Cancer. 2015 Aug; 62(8):1421-6. PMID: 25728605; PMCID: PMC4482780.
    7. Wattier RL, Dvorak CC, Hoffman JA, Brozovich AA, Bin-Hussain I, Groll AH, Castagnola E, Knapp KM, Zaoutis TE, Gustafsson B, Sung L, Berman D, Halasa NB, Abzug MJ, Velegraki A, Sharma TS, Fisher BT, Steinbach WJ. A Prospective, International Cohort Study of Invasive Mold Infections in Children. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):313-22. PMID: 26582870.
      View in: PubMed
    8. Levitz R, Wattier R, Phillips P, Solomon A, Lawler J, Lazar I, Weibel C, Kahn JS. Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific. Virol J. 2012 Sep 10; 9:190. PMID: 22962966; PMCID: PMC3463437.
    9. Wattier RL, Vázquez M, Weibel C, Shapiro ED, Ferguson D, Landry ML, Kahn JS. Role of human polyomaviruses in respiratory tract disease in young children. Emerg Infect Dis. 2008 Nov; 14(11):1766-8. PMID: 18976566; PMCID: PMC2630739.
    10. von Lackum K, Babb K, Riley SP, Wattier RL, Bykowski T, Stevenson B. Functionality of Borrelia burgdorferi LuxS: the Lyme disease spirochete produces and responds to the pheromone autoinducer-2 and lacks a complete activated-methyl cycle. Int J Med Microbiol. 2006 May; 296 Suppl 40:92-102. PMID: 16530477.
      View in: PubMed
    11. Babb K, von Lackum K, Wattier RL, Riley SP, Stevenson B. Synthesis of autoinducer 2 by the lyme disease spirochete, Borrelia burgdorferi. J Bacteriol. 2005 May; 187(9):3079-87. PMID: 15838035; PMCID: PMC1082833.
    12. Stevenson B, von Lackum K, Wattier RL, McAlister JD, Miller JC, Babb K. Quorum sensing by the Lyme disease spirochete. Microbes Infect. 2003 Sep; 5(11):991-7. PMID: 12941391.
      View in: PubMed
    Rachel's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.